Di Zhu

xuanwu hospital of capital medical university

H指数:17

被引数:1,058

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mechanism-Driven Design of Metal–Phenolic Networks: From Precision Assembly to Multidimensional Synergistic Therapy for Brain Diseases

机制驱动的金属-酚类网络设计：从精准组装到多维协同疗法治疗脑部疾病

Pharmaceutics

IF5.5

2026-09-220

Reversing the Warburg Effect: YW3-56 Induces Leukemia Differentiation via AKT-Mediated Glucose Metabolic Reprogramming

逆转Warburg效应：YW3-56通过AKT介导的葡萄糖代谢重编程诱导白血病分化

Pharmaceuticals 2025, Vol. 18, Page 1646

IF4.8

2025-10-310

OAAI

Ru Complex-Functionalized Au Nanospheres for Suppressing Tumor Growth and Metastasis: Photothermal Therapy Combined with Chemotherapy Using Nanoplatforms

International Journal of Nanomedicine

IF6.5

2025-10-210

OAAI

Oral ruthenium-based PAD4 inhibitor modulates immunogenic cell death and neutrophil extracellular traps in triple-negative breast cancer

口服钌基PAD4抑制剂调节三阴性乳腺癌中的免疫原性细胞死亡和中性粒细胞胞外 traps

Journal of Controlled Release

IF11.5

2025-08-150

PRE

A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-05-102

PRE

PAD4 Inhibitor-Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis

PAD4抑制剂功能化层状双氢氧化物纳米片协同声动力治疗/免疫治疗肿瘤转移

ADVANCED SCIENCE

IF14.1

2024-05-062

OAAI

Mitosis targeting in non-small lung cancer cells by inhibition of PAD4

HELIYON

IF3.6

2024-03-011

OAAI

pH-Responsive, Self-Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death

pH响应性自组装钌纳米药物: 对溶酶体和DNA的双重影响，用于协同化疗和免疫原性细胞死亡

SMALL

IF12.1

2024-02-274

PRE

Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-10-018

OAAI

Depression is a risk factor for noncompliance with antiviral medication treatment among Asian Americans with chronic hepatitis B

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2023-01-010

PRE

Efficient Preparation of Small-Sized Transition Metal Dichalcogenide Nanosheets by Polymer-Assisted Ball Milling

MOLECULES

IF4.6

2022-11-122

OAAI

PAD4 and Its Inhibitors in Cancer Progression and Prognosis

PHARMACEUTICS

IF5.5

2022-11-0837

OAAI

Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells

PHARMACEUTICAL BIOLOGY

IF4.8

2022-10-0619

OAAI

Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants

VACCINES

IF3.4

2022-07-2910

OAAI

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants

在接种前的小鼠中接种Omicron灭活疫苗可预防SARS-CoV-2原型和Omicron变体

VACCINES

IF3.4

2022-07-1911

OAAI

Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment

自组装pH响应性纳米花抑制PAD4和中性粒细胞胞外陷阱形成，改善肿瘤免疫微环境

ACTA PHARMACEUTICA SINICA B

IF14.6

2022-05-0117

OAAI

Developmental toxicity of fenbuconazole in zebrafish: Effects on mitochondrial respiration and locomotor behavior

TOXICOLOGY

IF4.6

2022-03-0114

PRE

Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy

NANOSCALE

IF5.1

2022-01-0133

RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety

RGD肽和PAD4抑制剂负载金纳米棒用于化学-光热联合治疗抑制肿瘤生长，预防肺转移并提高生物安全性

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2021-08-0111

OAAI

Detection of Osteoarthritis Inflammation by Single-Photon Emission Computed Tomography Based on an Inflammation-Targeting Peptide cFLFLF

MOLECULAR IMAGING AND BIOLOGY

IF2.5

2021-05-244

OAAI

Di Zhu

个人简介

教育背景

工作经历

荣誉奖项

研究方向